An experimental Parkinson’s drug missed its primary goal in a mid-stage trial, Roche said, in what is the second setback this week for candidate treatments for the neurodegenerative condition.
Original Source Link
![[VIDEO] ‘Evil’ Season 3: Mike Colter, Katja Herbers Interview](https://tvline.com/wp-content/uploads/2022/06/evil-season-3-preview-video-mike-colter-katja-herbers.jpg?w=620 "[VIDEO] ‘Evil’ Season 3: Mike Colter, Katja Herbers Interview")
Roche's Parkinson's Drug Candidate Misses Key Goal in Mid-Stage Study
PopularPosts
RecentPosts
From a tartan butler to a guitar concierge, these hotels have some of the best perks for business travelers
Here are the hotels in Europe that can take business...
JUST IN: U.S. Senate Approves Government Funding Bill Just in Time to Avoid Shutdown — White House Ceased Shutdown Preparations | The Gateway Pundit
(Photo by Anna Moneymaker/Getty Images) The U.S. Senate passed the...
Notre Dame routs Indiana in College Football Playoff to set up Sugar Bowl date with Georgia
Notre Dame is the answer to trivia forever.The Fighting Irish...
2024 Was the Year the Bottom Fell Out of the Games Industry
Games with Black leads and characters were derided as forced....
OpenAI’s o3 model aced a test of AI reasoning – but it’s still not AGI
OpenAI announced a breakthrough achievement for its new o3 AI...
Demi Moore and Nicole Kidman Could’ve Been Cast in ‘Wicked’
Two decades ago, the Wicked movie could’ve looked very different....
